We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Published in Gastroenterology

Journal Scan / Research · April 05, 2021

Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior TNF Inhibitor Failure Status

Clinical Gastroenterology and Hepatology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Amar Naik MD

Clinical Gastroenterology and Hepatology
Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status
Clin. Gastroenterol. Hepatol. 2021 Mar 05;[EPub Ahead of Print], WJ Sandborn, L Peyrin-Biroulet, AI Sharara, C Su, I Modesto, R Mundayat, LM Gunay, L Salese, BE Sands

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated